Healthcare provider profile · identity verified

John P Vaikutis, DO

Family Practice · AURORA, IL · NPI 1528098365

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	418	115
Amlodipine Besylate	Amlodipine Besylate	404	111
Levothyroxine Sodium	Levothyroxine Sodium	396	104
Rosuvastatin Calcium	Rosuvastatin Calcium	294	96
Losartan Potassium	Losartan Potassium	288	81
Metoprolol Succinate	Metoprolol Succinate	242	68
Pantoprazole Sodium	Pantoprazole Sodium	205	61
Tamsulosin Hcl	Tamsulosin Hcl	170	49
Metformin Hcl	Metformin Hcl	162	46
Lisinopril	Lisinopril	156	48
Metformin Hcl Er	Metformin Hcl	145	50
Gabapentin	Gabapentin	141	35
Omeprazole	Omeprazole	136	40
Alprazolam	Alprazolam	130	28
Tramadol Hcl	Tramadol Hcl	112	31
Meloxicam	Meloxicam	103	31
Escitalopram Oxalate	Escitalopram Oxalate	100	28
Hydrochlorothiazide	Hydrochlorothiazide	98	34
Lorazepam	Lorazepam	98	23
Simvastatin	Simvastatin	93	28
Prednisone	Prednisone	86	59
Allopurinol	Allopurinol	85	20
Hydralazine Hcl	Hydralazine Hcl	74	18
Ozempic	Semaglutide	74	15
Duloxetine Hcl	Duloxetine Hcl	73	17
Trazodone Hcl	Trazodone Hcl	72	20
Clopidogrel	Clopidogrel Bisulfate	70	16
Sertraline Hcl	Sertraline Hcl	68	20
Pravastatin Sodium	Pravastatin Sodium	67	20
Furosemide	Furosemide	66	20
Mirtazapine	Mirtazapine	66	14
Glipizide Er	Glipizide	65	19
Montelukast Sodium	Montelukast Sodium	65	19
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	58	17
Carvedilol	Carvedilol	56	17
Diclofenac Sodium	Diclofenac Sodium	55	16
Citalopram Hbr	Citalopram Hydrobromide	50	15
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	50	12
Memantine Hcl	Memantine Hcl	50	13
Metoprolol Tartrate	Metoprolol Tartrate	49	17
Pregabalin	Pregabalin	48	suppressed
Valsartan	Valsartan	48	17
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	47	12
Fluticasone Propionate	Fluticasone Propionate	47	19
Synthroid	Levothyroxine Sodium	47	11
Famotidine	Famotidine	46	16
Albuterol Sulfate Hfa	Albuterol Sulfate	45	21
Atenolol	Atenolol	44	12
Celecoxib	Celecoxib	44	14
Jardiance	Empagliflozin	42	12
Temazepam	Temazepam	42	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	41	suppressed
Spironolactone	Spironolactone	41	12
Potassium Chloride	Potassium Chloride	39	14
Warfarin Sodium	Warfarin Sodium	39	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	27
Bupropion Xl	Bupropion Hcl	35	suppressed
Azelastine Hcl	Azelastine Hcl	34	12
Finasteride	Finasteride	34	12
Eliquis	Apixaban	33	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	32	suppressed
Glimepiride	Glimepiride	32	suppressed
Bumetanide	Bumetanide	31	suppressed
Trulicity	Dulaglutide	31	suppressed
Eszopiclone	Eszopiclone	29	suppressed
Azithromycin	Azithromycin	28	23
Donepezil Hcl	Donepezil Hcl	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	13
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Ipratropium Bromide	Ipratropium Bromide	25	11
Zolpidem Tartrate	Zolpidem Tartrate	25	11
Cephalexin	Cephalexin	24	21
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Colchicine	Colchicine	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	20	suppressed
Clonazepam	Clonazepam	20	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Buspirone Hcl	Buspirone Hcl	18	suppressed
Propranolol Hcl Er	Propranolol Hcl	18	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	17	suppressed
Enalapril Maleate	Enalapril Maleate	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	16	suppressed
Cefdinir	Cefdinir	16	11
Tizanidine Hcl	Tizanidine Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	11
Etodolac	Etodolac	15	suppressed
Fluconazole	Fluconazole	15	suppressed
Fosfomycin Tromethamine	Fosfomycin Tromethamine	15	suppressed
Levemir Flexpen	Insulin Detemir	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Risperidone	Risperidone	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Fenofibrate	Fenofibrate,micronized	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Hydrocortisone	Hydrocortisone	14	suppressed
Linzess	Linaclotide	14	suppressed
Nystatin	Nystatin	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Ezetimibe	Ezetimibe	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Glipizide	Glipizide	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	11
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	13	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	12	suppressed
Lacosamide	Lacosamide	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Rybelsus	Semaglutide	12	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error